World Patient Safety Day: Protecting Participants in Every Clinical Trial

Around 1 in every 10 patients is harmed in a health care setting, and more than 3 million deaths occur annually due to unsafe care. That sobering statistic from the World Health Organization (WHO) is exactly why September 17, World Patient Safety Day, matters so much. Every year, this global awareness day reminds us of […]
September 16, 2025
Dr. Debra Weinstein
Dr. Debra Weinstein
Dr. Weinstein is a leading expert in decentralized clinical trials at Science 37, where she has been instrumental in advancing remote research opportunities since 2017. With active medical licensure in 46 states, she oversees a wide range of studies across diverse therapeutic areas, ensuring broader patient access to cutting-edge treatments.

A board-certified internist, Dr. Weinstein has over two decades of experience in clinical research. She has served as a principal investigator on more than 200 trials and has founded multiple research organizations specializing in internal medicine, rheumatology, orthopedics, and pain management. Recognized for her contributions to medical research, she has been named "Woman of the Year" by the National Association of Professional Women.

Around 1 in every 10 patients is harmed in a health care setting, and more than 3 million deaths occur annually due to unsafe care. That sobering statistic from the World Health Organization (WHO) is exactly why September 17, World Patient Safety Day, matters so much.

Every year, this global awareness day reminds us of a simple truth: patient safety is the foundation of quality care. Whether you’re visiting your family doctor, giving birth, or considering joining a clinical trial, your safety should always come first.

Yet if you’ve ever wondered whether clinical trials are safe, you’re not alone. Skepticism is understandable. With so much misinformation circulating online, it’s easy to fear being treated as a “test subject” or worry about unexpected side effects.

On World Patient Safety Day, it’s worth looking closer at what really happens in clinical research. The reality is reassuring: clinical trials are among the most carefully regulated and ethically monitored areas of modern health care.

This blog will help you understand why patient safety is at the heart of every trial, the protections in place for participants, and how being part of research not only safeguards you but also advances public health for everyone.

What Is World Patient Safety Day?

World Patient Safety Day happens every year on September 17, and it was created by the World Health Organization to protect patients from harm. The idea is simple: no one should be put at risk when they’re receiving health care.

Unsafe care is more common than most people realize. Mistakes in diagnosis, medication errors, or gaps in hospital safety lead to millions of deaths worldwide each year. World Patient Safety Day raises awareness of these issues and pushes health workers, governments, and communities to do better.

Each year, the day focuses on a theme. In 2025, the spotlight is on safe care for every newborn and every child. Children are among the most vulnerable patients, and ensuring their safety also strengthens care for everyone.

So why does this matter if you’re considering a clinical trial? Because the same principles that guide World Patient Safety Day, safety first, preventing harm, protecting dignity, are the foundation of every trial. It’s not about being a “test subject.” It’s about being cared for and respected while helping improve treatment for yourself and others.

Why Safety in Clinical Trials Is Non-Negotiable

Every modern medical treatment—from vaccines to cancer therapies—exists because of clinical trials. But unlike myths might suggest, trials are not “wild experiments.” They are controlled studies designed with rigorous safeguards.

In fact, clinical trials have more layers of oversight than most areas of routine care. That’s because researchers, regulators, and health care systems recognize the responsibility that comes with inviting patients into research.

Here’s why safety is non-negotiable:

  • Ethical foundations: Clinical trials follow the Declaration of Helsinki and Good Clinical Practice guidelines, which prioritize patient well-being above all else.
  • Independent review: Before a trial can even begin, it must be approved by an ethics committee or Institutional Review Board (IRB) to ensure participant protection.
  • Regulatory oversight: Agencies like the FDA (in the U.S.) or EMA (in Europe) closely monitor protocols, data, and patient safety throughout the study.
  • Continuous monitoring: Every potential adverse event, from mild side effects to unexpected reactions is documented, investigated, and reported.

Clinical trials cannot move forward without proving that patient safety comes first.

The Layers of Protection in Place

If you’re considering joining a trial, it may help to understand the many layers of protection built around participants. These are like safety nets designed to catch risks before they ever reach you.

1. Informed Consent 

Informed consent is a process where researchers explain the purpose of the study, what’s expected, possible risks, and your rights. You can ask questions, take your time, and ultimately decide if it feels right for you. Importantly: you can leave a trial at any time, without penalty.

2. Protocols & Controlled Studies

Every clinical trial follows a strict protocol, a detailed plan that spells out exactly how the study will run. From how medications are given to how side effects are tracked, nothing is left to chance. This ensures the study remains a controlled study where your health is monitored closely.

3. Oversight by Experts

Health workers, nurses, and physicians trained in research safety are with you every step of the way. Trials are not isolated labs. They’re supported by entire health care systems who are committed to safety and transparency.

4. Monitoring Adverse Events

Even with the best planning, side effects can happen. That’s why adverse event monitoring is continuous. If something unexpected occurs, safety boards and regulators step in immediately to adjust or stop the study if necessary.

5. Global Standards

Because the WHO and other international bodies prioritize patient safety, trials conducted in different countries must align with global health standards. That means participants should expect the same protections no matter where a trial occurs.

Patients Are Partners, Not Test Subjects

One of the biggest myths about clinical trials is that participants are treated like “guinea pigs.” The truth couldn’t be more different. When you join a trial, you are a partner in science. Your contribution is valued by researchers and future patients who may benefit from safer, more effective treatments.

This partnership means:

  • You are listened to. Your feedback about symptoms or side effects is critical.
  • You are supported. Health workers prioritize safe care at every stage.
  • You are respected. Your participation is voluntary, and your rights are protected by law.

Addressing Common Fears and Myths

It’s normal to feel hesitant about clinical research. Let’s address a few common concerns:

  • I’ll be given unsafe medication.” In reality, trials only progress after extensive lab and early-phase testing to ensure safety. You’re never given a treatment blindly.
  • If something goes wrong, I’m stuck.” This is simply not true. Trials have built-in safety pauses. If a preventable harm or risk is detected, studies are adjusted or stopped.
  • I’m just a number.” Far from it. Your health outcomes are central to the trial. Every participant’s safety is carefully tracked, and studies exist to improve diagnosis, medication safety, and safe care for patients.

When you know the facts, it becomes easier to separate rumors from reality.

Why Patient Safety Benefits Everyone

The ripple effects of patient safety go far beyond one trial. When clinical research prioritizes safety, it strengthens entire health care systems, improves health outcomes, and reduces patient harm.

  • Policy-makers can create stronger protections for patients.
  • Health workers gain tools and training to deliver safer care.
  • Member states within the WHO share insights to improve global health.
  • Families benefit when unsafe care and its devastating consequences are prevented.

On World Patient Safety Day, this shared responsibility reminds us that when one patient is safe, entire communities are safer too.

Safety First, Always

If you’ve been considering new treatment options or simply want to contribute to advancing medicine, participating in a clinical trial could be a safe and meaningful option.

At Science 37, patient safety is at the heart of every trial. With decentralized clinical trials, you can take part from the comfort of your home, knowing that rigorous standards and real-time monitoring are always in place.

Your health. Your choice. Your safety. If you’re ready to explore whether a clinical trial is right for you, consider joining one of Science 37’s ongoing studies today.

hello world!

Read More

A female healthcare provider in a white lab coat consulting with a smiling patient about metabolic health. On the desk are a measuring tape and medical devices, symbolizing GLP-1 weight loss and clinical trial monitoring.
GLP-1 Agonists: The Future of Metabolic and Heart Health
In recent years, it has been nearly impossible to open a news app or scroll through social media without seeing a headline about GLP-1 agonists. Often framed strictly through the lens of weight loss, these medications have sparked a global conversation about body image and the "pills vs. pens" debate. However, focusing solely on the […]
Read More
A young girl smiling brightly at her caregiver in a comfortable home setting, representing the improved quality of life and comfort that at-home LGS clinical trials aim to support.
Beyond the Seizures: Managing the Cognitive and Behavioral Impact of Lennox-Gastaut Syndrome
For many families living with Lennox-Gastaut Syndrome (LGS), the daily focus is often—understandably—on seizure control. When you are managing multiple types of seizures, including dangerous drop seizures that can lead to injury, the physical safety of your loved one is the immediate priority. However, LGS is a multifaceted condition that extends far beyond the electrical […]
Read More
A mother sitting on a couch gently embracing her infant, reflecting the dedicated caregiver support required for families managing Dravet syndrome.
The Evolution of Dravet Syndrome Care: New Frontiers in Rare Epilepsy Research
For families living with Dravet syndrome, the journey often begins with a terrifying milestone: a prolonged, fever-related seizure in the first year of life. What starts as a frightening "first" quickly evolves into a complex, lifelong management of treatment resistant epilepsy. However, we are entering a transformative era in rare epilepsy research. We are moving […]
Read More
1 2 3 30
© 2026 Science 37 | All Rights Reserved